CAS No.: 2007885-39-2
rel-(3-((4-(Aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)((3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone Catalog No. CSN22481
Synonyms: GB2064
PAT-1251 is a potent, selective and oral Lysyl Oxidase-Like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 has entered clinical development with the potential to treat a number of fibrotic diseases.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT02852551 Healthy Phase 1 Completed - United Kingdom ... more >> Covance Clinical Research Unit Ltd. Leeds, United Kingdom, LS2 9LH Collapse <<
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 2007885-39-2 | 储存条件 |
|
|||
| 分子式 | C18H17F4N3O3 | 运输 | 蓝冰 | |||
| 分子量 | 399.34 | 别名 | GB2064 | |||
| 溶解度 |
|
动物实验配方 |
